Latest Technology News

Prophecy International flags higher churn and softer US sales for its Snare product, prompting a conservative FY2026 outlook and $3.2 million in annual cost savings.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

QuickFee Limited has divested its US Pay Now payments business for US$26.35 million while keeping its US Finance operations and loan book, withdrawing FY26 earnings guidance amid ongoing tax and transaction cost assessments.

Elsight has secured a US$5.35 million contract with a European defence OEM, pushing its 2025 orders to US$23.3 million, a staggering 1000% increase over 2024. The company’s rising deliveries and upcoming ASX index inclusions mark a pivotal growth phase.

Ardea Resources updates on the Kalgoorlie Nickel Project’s Goongarrie Hub, announcing a delay in the Definitive Feasibility Study completion to early 2026 while highlighting ongoing technical advances and strong JV collaboration.

Anson Resources has begun earthworks to re-establish the drill pad at its Mt Fuel-Skyline Geyser well in Utah, aiming to enhance lithium resource estimates at the Green River Lithium Project.

Peak Rare Earths has secured an increased cash offer from Shenghe Resources, valuing the company at A$195 million. An independent expert confirms the revised scheme remains fair and reasonable for shareholders.

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, reshuffling key constituents across multiple S&P/ASX indices effective September 22. The changes highlight shifting market dynamics with notable additions and removals in sectors ranging from technology to resources.

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, with significant additions and removals across multiple ASX indices set to take effect before market open on September 22.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Felix Group Holdings reminds shareholders that its Share Purchase Plan closes on 9 September, offering shares at a slight discount following a $16 million placement. Eligible investors in Australia and New Zealand have a final chance to participate without brokerage fees.

Lake Resources N.L. has scheduled an Extraordinary General Meeting on 7 October 2025 to seek shareholder approval for the second tranche of its $12 million placement and the issuance of new options to investors and directors.